RRM2 and breast cancer: have shown that promoters of the protein regulator of cytokinesis 1 (PRC1) and ribonuclease reductase 2 (RRM2) genes can be used in targeting breast cancer cells because these promoters exhibit strong gene expression similar to that driven by the CMV promoter.60